Menu

Bronze Age Plague Sequenced

Plague-causing bacteria may have been around as early as 5,000 years ago, though a genomic analysis suggests that ancient strains were less contagious.

Oct 26, 2015
Karen Zusi

RASMUSSEN ET AL./CELL 2015

Plague bacteria (Yersinia pestis) were recently discovered in Bronze Age skeletons, pushing back the recorded origin of plague by about 3,000 years. The newfound ancient strains are genetically distinct from modern-day strains. An international team reported its findings last week (October 22) in Cell.

Researchers led by Eske Willerslev of the University of Copenhagen were searching for the cause of Bronze Age human migrations in Europe and Asia, circa 3,000 BC to 1,000 BC, suspecting that disease might have been a driving factor. So the team sequenced 89 billion DNA sequences from 101 Bronze Age specimens obtained from museums and excavations.

Seven of the specimens contained Y. pestis DNA. Most of the ancient bacterial genomes lacked a gene known to protect the pathogen while it’s inside the flea gut, suggesting that the plague was not spread easily by fleas. The ancient Y. pestis bacteria also lacked a mutation that helps present-day strains avoid detection by the host’s immune system. The authors suggest that Y. pestis did not evolve into its destructive flea-borne form until the beginning of 1,000 BC.

“It’s really cool that they can pinpoint the acquisition of key genes that allow the movement of this bacteria into fleas,” evolutionary geneticist Hendrik Poinar of McMaster University in Canada, who was not involved with the study, told Science.

“At that time we have a kind of intermediate plague,” study coauthor Simon Rasmussen from the Technical University of Denmark told Smithsonian. “These Bronze Age strains couldn't cause bubonic plague, but they caused septicemic plague in the blood and pneumonic plague in the lungs, which you can transmit through the air whenever you sneeze or cough.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening